Neuro- & Biofeedback in Nonsuicidal Self-injury

Status Recruiting

Clinical Trial Summary

Nonsuicidal self-injury (NSSI) is defined as the direct, deliberate destruction of one's own body tissue without suicidal intent, typically including behaviors such as cutting, burning, or hitting oneself. The risk of engaging in NSSI is particularly high during adolescence. NSSI is associated with impairments in emotion regulation and NSSI behavior serves as an attempt to regulate emotion. We propose to examine whether training adolescents with NSSI to self-regulate using emotion regulation skills to down-regulate hemodynamic activity of the salience network, involved in emotional processing. Moreover, we propose to examine whether limbic-prefrontal cortex connectivity can be increased following neurofeedback, thereby helping adolescents find an optimal way to emotionally regulate with the help of neurofeedback, instead of engaging in NSSI to regulate emotions. We also aim to examine effects of real-time biofeedback by investigating if adolescents can regulate their psychophysiological activity during emotional reactivity with biofeedback. Sixty participants with NSSI will be recruited and offered either real-time functional magnetic resonance imaging (rt-fMRI-NF) (n = 30) or real-time biofeedback (n = 30) training. Participants each each condition will then be randomized to either an active or a control condition (n = 15/group). Participants will take part in three runs of feedback training. Changes in emotional reactivity as measured with facial electromyography (EMG) before and after feedback training will be the proximal outcome measure together with changes of the blood oxygenation level dependent (BOLD) response during real-time fMRI-neurofeedback for the neurofeedback training. Proximal outcome measures for the biofeedback will include psychophysiological measures of emotional reactivity (facialEMG). More distal outcome measures for both neuro- and biofeedback will be measures of NSSI: frequency, methods and severity as well as self-report measures of difficulties with regulating emotions, emotional reactivity and psychiatric symptoms.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05656001
Study type	Interventional
Source	Region Östergötland
Contact	Maria Zetterqvist, PhD
Phone	+46 10-1034339
Email	maria.zetterqvist@regionostergotland.se
Status	Recruiting
Phase	N/A
Start date	September 10, 2021
Completion date	March 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05702086` - Making SPARX Fly in Nunavut: Pilot Testing an E-intervention for Boosting Resilience Against Youth Depression	N/A
Completed	`NCT05684614` - Interoception and Emotion Regulation
Completed	`NCT05376397` - Testing THRIVE 365 for Black Sexual Minority Men (On The Daily)	N/A
Completed	`NCT04110548` - Emotion and Craving Regulation Among Individuals With Internet Gaming Disorders	N/A
Not yet recruiting	`NCT05558527` - The Social Regulation of Threat-related Vigilance and Arousal	N/A
Recruiting	`NCT03039387` - Effects of tDCS on Cognitive Control and Emotion Regulation in Depressed Patients	N/A
Recruiting	`NCT06024083` - Skills Video Intervention for Chinese/Chinese Americans	N/A
Recruiting	`NCT05867316` - Supplementing Brief Psychotherapy With a Mobile App	N/A
Recruiting	`NCT05949047` - Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease	N/A
Recruiting	`NCT06033053` - Real-time Neurofeedback Training of Fronto-limbic Regions Functional Connectivity	N/A
Recruiting	`NCT05390034` - Improving Emotion Regulation Flexibility: Testing the Efficacy of an Emotion Regulation Program in College Students	N/A
Recruiting	`NCT06049407` - Intervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood	N/A
Recruiting	`NCT05131425` - Facing Your Fears: Adolescents With ASD and Intellectual Disability	N/A
Completed	`NCT04999514` - Examining the Effects of Parenting Interventions on Children With Attention-Deficit / Hyperactivity Disorder (AD/HD) and Their Parents	N/A
Completed	`NCT05149066` - #KindGirlsInACTion: A Programme for the Promotion of Mental Health of Female Adolescents	N/A
Active, not recruiting	`NCT05264415` - Intergenerational Transmission of Traumatic Stress	N/A
Completed	`NCT03698591` - Testing a Neurocognitive Model of Distancing Using Transcranial Magnetic Stimulation.	N/A
Enrolling by invitation	`NCT05542498` - Promoting Stress Management and Engagement in Introductory Physics Courses With Mindfulness and Relaxation	N/A
Completed	`NCT03979092` - Interprofessional Advanced Cardiac Life Support Training on Collaborative Skills, Self-Efficacy And Emotion Regulation	N/A
Not yet recruiting	`NCT05586425` - Neuroplastic Adaptations in Youth at High Risk for Developing Psychopathology	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Neuro- and Biofeedback in Nonsuicidal Self-injury

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms